|
1
|
Pui CH, Relling MV and Downing JR: Acute
lymphoblastic leukemia. N Engl J Med. 350:1535–1548. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Iughetti L, Bruzzi P, Predieri B and
Paolucci P: Obesity in patients with acute lymphoblastic leukemia
in childhood. Ital J Pediatr. 38:42012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dalmasso P, Pastore G, Zuccolo L, et al:
Temporal trends in the incidence of childhood leukemia, lymphomas
and solid tumors in north-west Italy, 1967–2001. A report of the
Childhood Cancer Registry of Piedmont. Haematologica. 90:1197–1204.
2005.PubMed/NCBI
|
|
4
|
Redaelli A, Laskin BL, Stephens JM,
Botteman MF and Pashos CL: A systematic literature review of the
clinical and epidemiological burden of acute lymphoblastic
leukaemia (ALL). Eur J Cancer Care (Engl). 14:53–62. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Smith MA, Seibel NL, Altekruse SF, et al:
Outcomes for children and adolescents with cancer: challenges for
the twenty-first century. J Clin Oncol. 28:2625–2634. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Turner BC, Ottey M, Zmonjic DB, et al: The
fragile histidine triad/common chromosome fragile site 3B locus and
repair-deficient cancer. Cancer Res. 62:4054–4060. 2002.PubMed/NCBI
|
|
7
|
Nunez MI, Ludes-Meyer J, Abba MC, et al:
Frequent loss of WWOX expression in breast cancer: correlation with
estrogen receptor status. Breast Cancer Res Treat. 89:99–105. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ilsley JL, Sudol M and Winder SJ: The WW
domain: linking cell signaling to the membrane cytoskeleton. Cell
Signal. 14:183–189. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohta M, Inoue H, Cotticelli MG, et al: The
FHIT gene, spanning the chromosome 3p14.2 fragile site and renal
carcinoma-associated t (3;8) breakpoint, is abnormal in digestive
tract cancers. Cell. 84:587–597. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bednarek AK, Laflin KJ, Daniel RL, Liao Q,
Hawkins KA and Aldaz CM: WWOX, a novel WW domain-containing protein
mapping to human chromosome 16q2.33–2.41, a region frequently
affected in breast cancer. Cancer Res. 60:2140–2145. 2000.
|
|
11
|
Aqeilan RI and Croce CM: WWOX in
biological control and tumorigenesis. J Cell Physiol. 212:307–310.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sozzi G, Tornielli S, Tagliabue E, et al:
Absence of Fhit protein in primary lung tumor and cell lines with
FHIT gene abnormalities. Cancer Res. 57:5207–5212. 1997.PubMed/NCBI
|
|
13
|
Tseng JE, Kemp BL, Khuri FR, et al: Loss
of Fhit is frequent in stage I non-small cell lung cancer and in
the lungs of chronic smokers. Cancer Res. 59:4798–4803.
1999.PubMed/NCBI
|
|
14
|
Mori M, Mimori K, Shiraishi T, et al:
Altered expression of Fhit in carcinoma and precarcinomatous
lesions of the esophagus. Cancer Res. 60:1177–1182. 2000.PubMed/NCBI
|
|
15
|
Connolly DC, Greenspan DL, Wu R, et al:
Loss of Fhit expression in invasive cervical carcinomas and
intraepithelial lesions associated with invasive disease. Clin
Cancer Res. 6:3505–3510. 2000.PubMed/NCBI
|
|
16
|
Guler G, Uner A, Guler N, et al:
Concordant loss of fragile gene expression early in breast cancer
development. Pathol Int. 55:471–478. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kaghad M, Bonnet H, Yang A, et al:
Monoallelically expressed gene related to p73 at 1p36, a region
frequently deleted in neuroblastoma and other human cancers. Cell.
90:809–819. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Aqeilan RI, Pekarsky Y, Herrero JJ, et al:
Functional association between Wwox tumor suppressor protein and
p73, a p53 homolog. Proc Natl Acad Sci USA. 101:4401–4406. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Agrawal S, Unterberg M, Koschmieder S, et
al: DNA methylation of tumor suppressor genes in clinical remission
predicts the relapse risk in acute myeloid leukemia. Cancer Res.
67:1370–1377. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Esteller M: CpG island hypermethylation
and tumor suppressor genes: A booming present, a brighter future.
Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia-Manero G, Daniel J, Smith TL, et
al: DNA methylation of multiple promoter-associated CpG islands in
adult acute lymphocytic leukemia. Clin Cancer Res. 8:2217–2224.
2002.PubMed/NCBI
|
|
22
|
Roman-Gomez J, Jimenez-Velasco A,
Castillejo JA, et al: Promoter hypermethylation of cancer-related
genes: A strong independent prognostic factor in acute
lymphoblastic leukemia. Blood. 104:2492–2498. 2004. View Article : Google Scholar
|
|
23
|
Nephew KP and Huang TH: Epigenetic gene
silencing in cancer initiation and progression. Cancer Lett.
190:125–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuroki T, Trapasso F, Shiraishi T, et al:
Genetic alterations of the tumor suppressor gene WWOX in esophageal
squamous cell carcinoma. Cancer Res. 62:2258–2260. 2002.PubMed/NCBI
|
|
26
|
Yendamuri S, Kuroki T, Trapasso F, et al:
WW domain containing oxidoreductase gene expression is altered in
non-small cell lung cancer. Cancer Res. 63:878–881. 2003.PubMed/NCBI
|
|
27
|
Lin PM, Liu TC, Chang JG, Chen TP and Lin
SF: Aberrant FHIT transcripts in acute myeloid leukemia. Br J
Haematol. 99:612–617. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iwai T, Yokota S, Nakao M, et al: Frequent
aberration of FHIT gene expression in acute leukemias. Cancer Res.
58:5182–5187. 1998.PubMed/NCBI
|
|
29
|
Albitar M, Manshouri T, Gidel C, et al:
Clinical significance of fragile histidine triad gene expression in
adult acute lymphoblastic leukemia. Leuk Res. 25:859–864. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hallas C, Albitar M, Letofsky J, Keating
MJ, Huebner K and Croce CM: Loss of FHIT expression in acute
lymphoblastic leukemia. Clin Cancer Res. 5:2409–2414.
1999.PubMed/NCBI
|
|
31
|
Pluta A, Nyman U, Joseph B, Robak T,
Zhivotovsky B and Smolewski P: The role of p73 in hematological
malignancies. Leukemia. 20:757–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Campiglio M, Pekarsky Y, Menard S,
Tagliabue E, Pilotti S and Croce CM: FHIT loss of function in human
primary breast cancer correlates with advanced stage of the
disease. Cancer Res. 59:3866–3869. 1999.PubMed/NCBI
|
|
33
|
Donati V, Fontanini G, Dell'Omodarme M, et
al: WWOX expression in different histologic types and subtypes of
non-small cell lung cancer. Clin Cancer Res. 13:884–891. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nunez MI, Rosen DG, Ludes-Meyers JH, et
al: WWOX protein expression varies among ovarian carcinoma
histotypes and correlates with less favorable outcome. BMC Cancer.
5:642005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Płuciennik E, Kusińska R, Potemski P,
Kubiak R, Kordek R and Bednarek AK: WWOX - the FRA16D cancer gene:
expression correlation with breast cancer progression and
prognosis. Eur J Surg Oncol. 32:153–157. 2006.PubMed/NCBI
|
|
36
|
Alsop AE, Taylor K, Zhang J, Gabra H,
Paige AJ and Edwards PA: Homozygous deletions may be markers of
nearby heterozygous mutations: the complex deletion at FRA16D in
the HCT116 colon cancer cell line removes exons of WWOX. Genes
Chromosomes Cancer. 47:437–447. 2008. View Article : Google Scholar
|
|
37
|
Iwai M, Kiyoi H, Ozeki K, et al:
Expression and methylation status of the FHIT gene in acute myeloid
leukemia and myelodysplastic syndrome. Leukemia. 19:1367–1375.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Iliopoulos D, Guler G, Han SY, et al:
Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett.
232:27–36. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Corn PG, Kuerbitz SJ, van Noesel MM, et
al: Transcriptional silencing of the p73 gene in acute
lymphoblastic leukemia and Burkitt's lymphoma is associated with 5′
CpG island methylation. Cancer Res. 59:3352–3356. 1999.PubMed/NCBI
|
|
40
|
Zheng S, Ma X, Zhang L, et al:
Hypermethylation of the 5′ CpG island of the FHIT gene is
associated with hyperdiploid and translocation-negative subtypes of
pediatric leukemia. Cancer Res. 64:2000–2006. 2004.
|
|
41
|
Iwai M, Kiyoi H, Ozeki K, et al:
Expression and methylation status of the FHIT gene in acute myeloid
leukemia and myelodysplastic syndrome. Leukemia. 19:1367–1375.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang Y, Takeuchi S, Hofmann WK, et al:
Aberrant methylation in promoter-associated CpG islands of multiple
genes in acute lymphoblastic leukemia. Leuk Res. 30:98–102. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Paulsson K, An Q, Moorman AV, et al:
Methylation of tumour suppressor gene promoters in the presence and
absence of transcriptional silencing in high hyperdiploid acute
lymphoblastic leukaemia. Br J Haematol. 144:838–847. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Maeda N, Semba S, Nakayama S, Yanagihara K
and Yokozaki H: Loss of WW domain-containing oxidoreductase
expression in the progression and development of gastric carcinoma:
clinical and histopathologic correlations. Virchows Arch.
457:423–432. 2010. View Article : Google Scholar
|
|
45
|
Kosla K, Pluciennik E, Kurzyk A, et al:
Molecular analysis of WWOX expression correlation with
proliferation and apoptosis in glioblastoma multiforme. J
Neurooncol. 101:207–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Baykara O, Demirkaya A, Kaynak K, Tanju S,
Toker A and Buyru N: WWOX gene may contribute to progression of
non-small-cell lung cancer (NSCLC). Tumour Biol. 31:315–320. 2010.
View Article : Google Scholar : PubMed/NCBI
|
